Wenbin Jiang, Ph.D., has been the CEO of Cytek Biosciences, Inc., since June 2019. With a solid background in engineering, he holds a Ph.D. in Biomedical Engineering from Stanford University and has a history of innovation, boasting over 100 U.S....

Wenbin Jiang, Ph.D., has been the CEO of Cytek Biosciences, Inc., since June 2019. With a solid background in engineering, he holds a Ph.D. in Biomedical Engineering from Stanford University and has a history of innovation, boasting over 100 U.S. patents. Before joining Cytek, he co-founded E2O Communications, a fiber optic company that was eventually acquired. Dr. Jiang's experience shines in his mission to lead Cytek in advancing flow cytometry technology, aiding researchers in various fields. Under his leadership, Cytek has achieved significant corporate objectives, reflected in his performance-based bonuses, which amounted to over $300,000 in 2023. Despite fluctuations in company performance, he has consistently driven forward with a focus on growth and operational excellence. His journey showcases not just the technical, but also the strategic skills needed to guide a biotech company through a competitive landscape, allowing Cytek to emerge as a leader in its field.